๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3364 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:49 UTC
3364
Studies in scope
all four open statuses
1829
Recruiting now
open to new participants
503
Lead sponsors
across recruiting studies
Top sites
Seoul 2820 Daegu 550 Seongnam-si 485 Busan 464 Goyang-si 395
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca195 Seoul National University Hospital187 Yonsei University147 Samsung Medical Center142 Merck Sharp & Dohme LLC112
Site location
Seoul2820 Daegu550 Seongnam-si485 Busan464 Goyang-si395
All 252 locations
Target enrolment
to

Trials with a site in Seoul

2820 of 3364 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
DrugBesremi
PharmaEssentia
Phase 3
160
Daegu, Seongnam-si, Hwasun, Seocho, Seoul
2025-07-18
Recruiting
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
NCT07093476T2DM, Diabete Type 2, DM
DrugsMetformin·Dapagliflozin
Celltrion
Phase 3
171
Seoul
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Cheongju-si, Goyang-si, Incheon, Seoul
2025-07-17
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
NCT07015697Recurrent or Metastatic Solid Tumors
DrugTrastuzumab deruxtecan
Daiichi Sankyo
Phase 1
76
Seongnam-si, Seoul
2025-07-17
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745Alzheimer's Disease
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
426
Incheon, Seoul, Deagu
2025-07-16
Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494Early Alzheimer's Disease
Merck Sharp & Dohme LLC
Phase 2
340
Seoul
2025-07-16
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma
DrugsBevacizumab biosimilar·Calderasib·Cetuximab·Adrucil
Merck Sharp & Dohme LLC
Phase 3
477
Goyang-si, Seongnam-si, Suwon, Gangnam, Songpa-gu, Buk-Gu, Seoul
2025-07-16
Recruiting
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NCT07107230Advanced Stage Solid Tumors
DrugAmivantamab
Janssen Research & Development, LLC
Phase 1
400
Seoul
2025-07-15
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827Kidney Disease
DrugMezagitamab
Takeda
Phase 3
347
Suwon, Seongnam-si, Seoul
2025-07-15
Active, closed
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
NCT06963710Chronic Hepatitis B Infection
DrugALG-000184
Aligos Therapeutics
Phase 2
200
Ansan, Busan, Seoul, Ulsan, Yangsan
2025-07-15
Not yet open
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
NCT07013279Glabellar Lines
DrugBotox
Daewoong Pharmaceutical Co. LTD.
Phase 3
324
Seoul
2025-07-15
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
NCT07013474COVID-19 Infection
DrugsIbuzatrelvir·Remdesivir
Pfizer
Phase 3
300
Namdong-gu, Gwangju, Seoul
2025-07-14
Recruiting
Effect of L. Reuteri LM1063 on Sleep Health Improvement
NCT07498712Sleep Quality, Sleep Wake Disorders
Lactomason Co., Ltd.
Not applicable
80
Seoul
2025-07-14
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
NCT06976216Alzheimer's Disease
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
586
Gwangju, Seongnam, Seoul
2025-07-14
Not yet open
Prospective Validation of DL Model for Postoperative MACCE Prediction
NCT07054502Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Seoul National University Hospital
Observational
7,000
Seoul
2025-07-10
Recruiting
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06757764Cerebral Infarction, Stenosis Artery
DrugsCilostazol·Clopidogrel·Aspirin
Asan Medical Center
Phase 4
2,340
Seoul, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon
2025-07-10
Not yet open
Effect of Bilateral vs. Unilateral Alveolar Recruitment on Gas Exchange in Lung Resection
NCT07044661Lung Cancer Requiring Surgical Resection Under One-lung Ventilation
Yonsei University
Not applicable
198
Seoul
2025-07-10
Recruiting
GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification
NCT06722521Primary Prevention, Vascular Calcification
Asan Medical Center
Phase 4
7,435
Seoul
2025-07-09
Active, closed
The Effect of Two Prokinetics in Patients With Functional Dyspepsia
NCT07096921Functional Dyspepsia
DrugsDA-9701·Mosapride Citrate
Eunpyeong St. Mary's Hospital
Not applicable
92
Seoul
2025-07-08
Recruiting
Head and Neck Advanced Research for Multi-Omics and Optimized Immunotherapy
NCT07211139Head and Neck Cancer
Samsung Medical Center
Observational
30
Seoul
2025-07-08
Active, closed
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT06991556Metastatic Hormone-sensitive Prostate Cancer
DrugsLuxdegalutamide·Abiraterone·Enzalutamide
Novartis Pharmaceuticals
Phase 2
168
Seoul
2025-07-07
Not yet open
Association of Preoperative Coronary Calcium Score and Postoperative Atrial Arrythmia in Patients Undergoing Robot-assisted Esophagectomy: Prospective Observational Study
NCT07050030Patients Undergoing Robot-assisted Esophagectomy
Yonsei University
Observational
300
Seoul
2025-07-07
Recruiting
Heartburn, Gastroesophageal Reflux Disease
NCT07268820GERD
DrugsZastaprazan·Esomeprazole
Incheon St.Mary's Hospital
Phase 4
160
Ansan, Busan, Chilgok, Chuncheon, Gwangju, Incheon, Seoul, Yangsan
2025-07-07
By invitation
Clinical Effectiveness of a Patient-tailored Orthosis Based on 3-dimensional (3D) Scanner Modeling and 3D Printing Technology for Microstomia Caused by Burns : Pilot Study
NCT07264218Burn, 3D Printing, Microstomia, Split Thickness Skin Graft
Hangang Sacred Heart Hospital
Not applicable
10
Seoul
2025-07-05
Recruiting
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
NCT07083401Diabete Mellitus
DrugsDapagliflozin /Pioglitazone /Metformin HCl·Metformin HCl·Pioglitazone·Dapagliflozin
Boryung Pharmaceutical Co., Ltd
Phase 1
40
Seoul
2025-07-05
Recruiting
Algorithm Predicting Intraoperative Changes in Cardiac Output Using Capnography
NCT07061548General Anesthesia Using Endotracheal Intubation
Samsung Medical Center
Observational
2,005
Seoul
2025-07-03
Recruiting
Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage
NCT07267793Osteoarthritis, Knee Pain Arthritis, Cartilage Defects of the Knee, Knee Osteoarthritis
DALIM TISSEN Co., Ltd.
Not applicable
194
Seongnam-si, Seoul
2025-07-03
Recruiting
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer
NCT06616987Breast Cancer Metastatic
Yeon Hee Park
Phase 2
40
Seoul
2025-07-03
Active, closed
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07047118Prostatic Cancer, Castration-Resistant
DrugsLuxdegalutamide·Lu-PSMA
Novartis Pharmaceuticals
Phase 2
138
Seoul
2025-07-03
Recruiting
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
NCT07083388Diabetes Mellitus
DrugsDapagliflozin /Pioglitazone /Metformin HCl·Metformin HCl·Pioglitazone·Dapagliflozin
Boryung Pharmaceutical Co., Ltd
Phase 1
52
Seoul
2025-07-03
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
NCT06863272Castration-Resistant Prostatic Cancer, Metastasis
DrugsOpevesostat·Ifinatamab Deruxtecan·Abiraterone·Enzalutamide
Merck Sharp & Dohme LLC
Phase 1/2
360
Songpagu, Seoul
2025-07-03
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT07052903Transthyretin Amyloidosis With Cardiomyopathy
DrugNucresiran
Alnylam Pharmaceuticals
Phase 3
1,750
Incheon, Seoul
2025-07-02
Active, closed
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
NCT06981078Chronic Obstructive Pulmonary Disease
DrugVerekitug
Upstream Bio Inc.
Phase 2
666
Wลnju, Seongnam-si, Incheon, Seoul
2025-07-02
Recruiting
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352Alzheimers Disease
Hoffmann-La Roche
Phase 3
80,000
Gwangju, Gyeonggi-do, Incheon, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-07-02
Not yet open
The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study
NCT02492932Jugular Veins
Seoul National University Hospital
Not applicable
323
Seoul
2025-07-01
Recruiting
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
NCT07027891Myocardial Infarction (MI), Chest Pain Rule Out Myocardial Infarction
CHA University
Not applicable
4,670
Seoul
2025-07-01
Recruiting
A Study of AMC6156 in People With Sarcopenia
NCT07072195Sarcopenia in Elderly, Sarcopenia
Animuscure Inc.
Phase 2
80
Seongnam-si, Suwon, Seoul
2025-07-01
By invitation
Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease
NCT07399080PTA (Percutaneous Transluminal Angioplasty ), Femoropopliteal Artery Disease
Genoss Co., Ltd.
Observational
200
Seoul
2025-07-01
By invitation
Cuffless BP Monitoring in Hemodialysis
NCT07753876End-Stage Renal Disease
Gangnam Severance Hospital
Observational
240
Seoul
2025-07-01
Not yet open
THE EFFECTS OF A PROPRIOCEPTION-ENHANCING ASSISTIVE ORTHOSIS ON BALANCE AND JOINT SENSE IN GERIATRIC PATIENTS
NCT07017504Balance, Fall Prevention, Orthotic Device
Seoul National University Hospital
Not applicable
30
Seoul
2025-07-01
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
NCT06855277Prostate Cancer
DrugsAAA817·ARPI
Novartis Pharmaceuticals
Phase 3
940
Seoul
2025-07-01
Not yet open
A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease
NCT06885567Alzheimer Disease, Alzheimer' Disease
BeyondBio Inc.
Phase 2
90
Seoul
2025-07
Recruiting
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375Heart Failure
DrugCDR132L
Novo Nordisk A/S
Phase 2
200
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
2025-06-30
Active, closed
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
NCT06794554Chronic Pulmonary Aspergillosis
Mundipharma Research Limited
Phase 2
60
Gwangju, Seoul
2025-06-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsXeloda·Epirubicin·Adriamycin·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Goyang-si, Kyonggi-do, Taegu, Seoul
2025-06-30
Recruiting
Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
NCT07102446Pain, Chronic Pain, Opioid Analgesia, Opioid Use
Korea University Guro Hospital
Not applicable
70
Seoul
2025-06-27
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 2
987
Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wลnju
2025-06-27
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362Heart Failure
DrugCDR132L
Novo Nordisk A/S
Phase 2
200
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
2025-06-27
Not yet open
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer
NCT06977594Ovarian Cancer, Endometrial Cancer, Cervical Cancer
DrugPaclitaxel and Carboplatin
Seoul National University Hospital
Not applicable
1,000
Seoul
2025-06-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
2025-06-25
Recruiting
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
NCT07027254Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism
Seoul National University Hospital
Not applicable
90
Seoul
2025-06-25
Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
NCT07033026Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
NGM Biopharmaceuticals, Inc
Phase 2
136
Goyang, Incheon, Seoul, Suwon
2025-06-25
By invitation
The Video System to Provide a Developmental Training Guide for Preterm Infants
NCT06965842Premature Infants, Very Low Birth Weight Infants
Seoul National University Hospital
Not applicable
12
Seoul
2025-06-24
Recruiting
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NCT07192159Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal
Seoul National University Hospital
Not applicable
62
Seoul
2025-06-24
Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214Pulmonary Disease, Chronic Obstructive
DrugDepemokimab
GlaxoSmithKline
Phase 3
960
Seoul
2025-06-23
Recruiting
Streamlining Radioembolization for CCC and Metastatic Liver Cancer
NCT07043387Metastatic Colorectal Carcinoma (mCRC), Metastatic Liver Cancer, Cholangiocarcinoma
Seoul National University Hospital
Observational
60
Goyang-si, Seoul
2025-06-22
Recruiting
At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
NCT06891378Arthroplasty, Replacement, Shoulder, Reverse Total Shoulder Arthroplasty
Samsung Medical Center
Not applicable
100
Seoul
2025-06-20
Active, closed
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
NCT06736990Idiopathic Pulmonary Fibrosis
Calluna Pharma AS
Phase 2
150
Suwon, Gyeonggi-do, Seoul
2025-06-20
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
NCT06972446Rheumatoid Arthritis
DrugsABBV-8736·ABBV-701·Lutikizumab·Adalimumab
AbbVie
Phase 2
180
Cheonan-si, Suwon, Seoul
2025-06-20
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323Graves' Disease
DrugIMVT-1402
Immunovant Sciences GmbH
Phase 2
210
Daegu, Goyang, Guri-si, Seoul
2025-06-19
Recruiting
Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
NCT06948487Gastritis
Daewoong Pharmaceutical Co. LTD.
Observational
12,000
Seoul
2025-06-17
Active, closed
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
NCT06880744Ulcerative Colitis
DrugsRisankizumab·Vedolizumab
AbbVie
Phase 3
573
Busan, Daegu, Daejeon, Seongnam-si, Suwon, Gwangju, Seoul
2025-06-17
Recruiting
A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer
NCT07069335Ovarian Cancer
DrugOlaparib
Boryung Pharmaceutical Co., Ltd
Phase 1
24
Seoul
2025-06-17
By invitation
One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease
NCT07431437PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease
Genoss Co., Ltd.
Observational
300
Seoul
2025-06-17
Not yet open
Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
NCT06977347Severe Community-acquired Pneumonia (sCAP)
DrugsPiperacillin-tazobactam·Levofloxacin
CHOSEOK YOON
Not applicable
100
Seoul
2025-06-15
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
36
Seoul
2025-06-14
Recruiting
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
NCT06984952Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer
Seoul National University Hospital
Not applicable
308
Busan, Daegu, Daejeon, Goyang, Seongnam, Seoul, Suwon
2025-06-13
Recruiting
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
NCT06975410EGFR Overexpression, Locally Advanced Solid Tumor, Metastatic Solid Tumor
Yuhan Corporation
Phase 1/2
80
Seoul
2025-06-12
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsSonrotoclax·Venclexta·Obinutuzumab·Venetoclax
BeOne Medicines
Phase 3
630
Seogu, IlsandongGu GoyangSi, Seongnam-si, GangnamGu, SeochoGu, SeodaemunGu, Seoul
2025-06-11
Recruiting
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
NCT06972732Type 2 Diabetes
DrugMetformin
Boryung Pharmaceutical Co., Ltd
Phase 4
204
Seoul
2025-06-11
Active, closed
A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
NCT06964113Ulcerative Colitis
DrugFilgotinib
Eisai Korea Inc.
Phase 4
94
Busan, Daegu, Daejeon, Gyeonggi-do, Gyeongnam, Jungnam, Seoul
2025-06-11
Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
NCT06885034Gastrointestinal Neoplasms
DrugRisvutatug Rezetecan
GlaxoSmithKline
Phase 1/2
451
Seoul
2025-06-11
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568Endometrial Cancer
DrugsDoxorubicin·Docetaxel·Paclitaxel
BioNTech SE
Phase 3
480
Changwon, Daegu, Goyang, Seongnam, Seongnam-si, Seoul
2025-06-10
Recruiting
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
NCT06914609Angelman Syndrome
DrugObudanersen
Ionis Pharmaceuticals, Inc.
Phase 3
158
Seoul
2025-06-10
Recruiting
Streamlining Radioembolization for Small HCC
NCT06979219Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Observational
146
Goyang, Seongnam-si, Seoul
2025-06-10
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Gyeonggi-do, Seoul
2025-06-10
Recruiting
Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer
NCT06873763Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer
DrugsTrifluridine/Tipiracil·Bevacizumab
STCube, Inc.
Phase 1/2
52
Seongnam-si, Seoul
2025-06-09
Recruiting
The AIRTIVITYโ„ข Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892Bronchiectasis
DrugVerducatib
Boehringer Ingelheim
Phase 3
1,755
Anyang, Chungju, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wลnju
2025-06-09
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT06902558Autosomal Dominant Polycystic Kidney Disease
Calico Life Sciences LLC
Phase 2
240
Busan, Daegu, Seoul
2025-06-09
Recruiting
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
NCT06847867Myelodysplastic Syndromes
DrugMomelotinib
GlaxoSmithKline
Phase 2
80
Seongnam-si Gyeonggi-do, Seoul
2025-06-05
Recruiting
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
NCT06997627Tetanus-diphtheria-acellular Pertussis (Tdap)
DrugBoostrix
GC Biopharma Corp
Phase 1/2
120
Seoul
2025-06-05
Active, closed
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
NCT06581848Multiple Myeloma
DrugElranatamab
Pfizer
Observational
150
Seoul
2025-06-05
Recruiting
No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy
NCT06704945Breast Cancer, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy
Seoul National University Hospital
Phase 3
464
Seoul
2025-06-04
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222Leukemia, Myeloid, Acute
DrugsBleximenib·Azacitidine·Venetoclax
Janssen Research & Development, LLC
Phase 3
600
Daejeon, Goyang-si, Gyeonggi-do, Seoul
2025-06-04
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Seoul, Yangsan, Busan
2025-06-02
Not yet open
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
NCT06763744Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), High Bleeding Risk
DrugsClopidogrel·Aspirin
Samsung Medical Center
Phase 4
3,000
Seoul
2025-06-01
Not yet open
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects
NCT06993181Healthy
DrugDA-5222
Dong-A ST Co., Ltd.
Phase 1
48
Seoul
2025-06
Not yet open
A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes
NCT07004153Diabetes Mellitus
G2e Co., Ltd
Not applicable
152
Seoul
2025-06
Not yet open
Clinical Trial to Evaluate the Efficacy and Safety of Nexpowderโ„ข for Diverticular Bleeding in the Lower Gastrointestinal Tract
NCT06939907Lower Gastrointestinal Bleeding, Diverticular Bleeding
Next Biomedical Co., Ltd.
Not applicable
60
Cheongju-si, Daejeon, Gwangju, Sejong, Seoul, Yangsan
2025-06
Not yet open
Community-Based Remote Cardiac Rehabilitation Program for Pediatric Patients With Complex Congenital Heart Disease
NCT06912412Congenital Heart Disease (CHD), Complex Congenital Heart Disease, Congenital Heart Disease in Children
Seoul National University Hospital
Not applicable
10
Seoul
2025-05-31
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Seoul
2025-05-30
Active, closed
Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable Criterion Defining GMFCS Levels in Children Aged 2 to 6 Years With Cerebral Palsy
NCT07824531Cerebral Palsy
Samsung Medical Center
Observational
26
Seoul
2025-05-30
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
NCT06961565NF1 Mutation, Neurofibroma Plexiform, Neurofibroma, Plexiform, Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)
DrugPAS-004
Pasithea Therapeutics Corp.
Phase 1
56
Seoul, Sinchลn-dong
2025-05-30
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
NCT06682988Advanced High-Grade Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancers
DrugsMIRV·Mirvetuximab Soravtansine
AbbVie
Phase 2
110
Goyang-si, Seongnam, Seongnam-si, Daegu, Seoul
2025-05-28
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
NCT06787612Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
DrugsREGN10597·Ubamatamab·Sarilumab·Fianlimab
Regeneron Pharmaceuticals
Phase 2
297
Gyeonggi-do, Seongnam-si, Incheon, Daegu, Seoul
2025-05-28
Recruiting
Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC
NCT06819566Hepatocellular Carcinoma, Esophageal Varix, Bleeding Esophageal Varices
Asan Medical Center
Phase 2
44
Seoul
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Busan, Daegu, Daejeon, Seoul, Suwon, Wลnju
2025-05-27
Recruiting
A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants
NCT06786676Healthy
Amyloid Solution Inc
Phase 1
88
Seoul
2025-05-26
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
NCT06941272Malignant Neoplasm
DrugPatritumab deruxtecan
Merck Sharp & Dohme LLC
Phase 1/2
50
Seoul
2025-05-26
Recruiting
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
NCT06921837Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
Bolt Biotherapeutics, Inc.
Phase 1/2
122
Seongnam-si, Seoul
2025-05-26
Rows per page Showing 701–800 of 2820
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul?page=8

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,364 studies in total at the last sync on 26 Sep 2026, 19:49 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,820 of those studies with a site in Seoul.

How many clinical trials are recruiting in Seoul?

1,518 of the 2,820 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:49 UTC sync. A further 209 have not yet opened recruitment, 1,015 are active but closed to new participants, and 78 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.